Back to Journals » OncoTargets and Therapy » Volume 9

RETRACTED ARTICLE: MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition

Authors Jiang S, He X , Xia Y, Hu W, Luo J, Zhang J, Tao H

Received 4 December 2015

Accepted for publication 8 March 2016

Published 18 April 2016 Volume 2016:9 Pages 2305—2315

DOI https://doi.org/10.2147/OTT.S101853

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Min Li



This paper has been retracted.

Jiang SB, He XJ, Xia YJ, et al. Onco Targets Ther. 2016;9:2305-2315.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors were cooperative but were unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors were informed of this decision and do not agree with the retraction.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Creative Commons License © 2016 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.